PPARA and metabolic dysfunction-associated steatohepatitis: Our previous study demonstrated that EVs secreted from lanifibranor-stimulated iMSCs (pan PPAR-iMSC-EVs) potently reduced steatosis, inflammation, and ER stress in a mice model of non-alcoholic steatohepatitis (NASH).